Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 12
Submit an article Journal homepage
420
Views
9
CrossRef citations to date
0
Altmetric
Pain

An abuse-deterrent, microsphere-in-capsule formulation of extended-release oxycodone: alternative modes of administration to facilitate pain management in patients with dysphagia

Bill H. McCarbergUniversity of California at San Diego School of Medicine, San Diego, CA, USA; Correspondence[email protected]
,
Ernest A. KopeckyCollegium Pharmaceutical Inc., Canton, MA, USA
,
Melinda O’ConnorCollegium Pharmaceutical Inc., Canton, MA, USA
,
Ann MarseillesCollegium Pharmaceutical Inc., Canton, MA, USA
,
Ravi K. VaranasiCollegium Pharmaceutical Inc., Canton, MA, USA
,
Christy ThompsonCollegium Pharmaceutical Inc., Canton, MA, USA
&
Alison B. FlemingCollegium Pharmaceutical Inc., Canton, MA, USA
 show all
Pages 1975-1982 | Received 25 May 2016, Accepted 04 Aug 2016, Published online: 26 Sep 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mary Coyne & Julie Regan. (2022) Measuring the social impact of contemporary dysphagia research: an altmetric analysis. Speech, Language and Hearing 25:1, pages 46-58.
Read now
Rand Ahmad, Samaneh Alaei & Hamid Omidian. (2018) Safety and performance of current abuse-deterrent formulations. Expert Opinion on Drug Metabolism & Toxicology 14:12, pages 1255-1271.
Read now
Sebastiano Mercadante. (2017) Oxycodone extended release capsules for the treatment of chronic pain. Expert Review of Neurotherapeutics 17:5, pages 427-431.
Read now

Articles from other publishers (6)

. (2017) Treat chronic pain with appropriate non-oral formulations of opioids in patients who have difficulty swallowing. Drugs & Therapy Perspectives 33:12, pages 566-570.
Crossref
Stephen P. Mayock, Said Saim & Alison B. Fleming. (2017) In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations. Clinical Drug Investigation 37:12, pages 1117-1124.
Crossref
Michael J Brennan, Ernest A Kopecky, Ann Marseilles, Melinda O'Connor & Alison B Fleming. (2017) The comparative pharmacokinetics of physical manipulation by crushing of Xtampza ® ER compared with OxyContin ® . Pain Management 7:6, pages 461-472.
Crossref
Sebastiano Mercadante. (2017) Options for Treating Pain in Cancer Patients with Dysphagia. Drugs 77:6, pages 629-635.
Crossref
Yvette N. Lamb, Karly P. Garnock-Jones & Susan J. Keam. (2016) Oxycodone DETERx® ER Capsules: A Review in Severe, Chronic Pain. Drugs 76:18, pages 1759-1769.
Crossref
Jeff Gudin. (2016) Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain. Pain and Therapy 5:2, pages 171-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.